Dengue Testing Market Analysis By Industry Size, Share, Revenue Growth, Development And Demand Forecast To 2030

Research Nester released a report titled “Dengue Testing Market: Global Demand Analysis & Opportunity Outlook 2030,” which delivers a detailed overview of the global dengue testing market in terms of market segmentation by test type, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global dengue testing market is projected to grow with a moderate CAGR during the forecast period, i.e., 2022-2030, on account of the increasing occurrence of dengue virus infections, and the rise in adoption of cost-effective and reliable testing kits. In addition, the high prevalence of dengue infections results in growth in demand for dengue testing, which is projected to contribute majorly to the market growth. As per the World Health Organization statistics, the stated number of dengue virus infections surged from 505,430 in 2000 to greater than 2.4 million in 2010 and 5.2 million in 2019.

Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-3278

The market is segmented by test type into ELISA-based test, RT-PCR amplification assay, dengue IgG/IgM rapid test, and others. Among these segments, the ELISA-based test segment is anticipated to hold the largest share during the forecast period in the global dengue testing market ascribing to the rising adoption of this test by end-users owing to its higher sensitivity in diagnosing dengue. Additionally, on the basis of end-user, the diagnostic centers segment is expected to grow significantly, which can be credited to the higher preference of these centers for conducting dengue testing over other facilities.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which the market in Asia Pacific is projected to hold the largest share throughout the forecast period owing to growth in government expenditure on developing healthcare facilities and the high prevalence of dengue-related infections in the region. The market in North America is also expected to grow significantly attributing to the significant research and development investments in the region, accompanied by the advancements in the healthcare infrastructure.

Get Exclusive Sample Copy of This Report @ https://www.researchnester.com/sample-request-3278

Increasing Occurrence of Dengue Virus Infections and Rise in Adoption of Cost-Effective and Reliable Testing Kits to Drive Market Growth

According to the World Health Organization, dengue is presently an endemic disease in greater than 100 countries. The Americas, South-East Asia and Western Pacific regions are worst affected due to dengue, with the Asian region representing 70% of the total dengue cases globally.

The global warming and extreme weather-related events caused due to major climate changes have aggravated the spread of dengue. This factor has raised the need for effective diagnostic tests to fulfill the healthcare necessities of the population in the regions affected. Additionally, coupled with the hike in the adoption of cost-effective and reliable testing kits are expected to boost the market growth in the upcoming years.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

However, the unavailability of efficient dengue testing tools in lower-income countries and low per capita income of the population in these regions are some of the factors that are estimated to restrain market growth in the near future.

This report also provides the existing competitive scenario of some of the key players of the global dengue testing market, which includes company profiling of Abbott Laboratories, InBios International, Inc., EUROIMMUN AG, CERTEST BIOTEC SL, Abnova Corporation, ThermoFisher Scientific inc., F. Hoffmann-La Roche Ltd, Quest Diagnostics, DiaSorin Group, NovaTec Immundiagnostica GmbH, and others. The profiling enfolds key information of the companies, which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts detailed overview of the global dengue testing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities, and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/dengue-testing-market/3278

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact Us

AJ Daniel
Email: info@researchnester.com
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]

Self Service Business Intelligence (BI) Market
Wearable Asthma Monitor Market
Smart Asthma Monitoring Devices Market
Graphene Composites Market

Leave a Reply

Your email address will not be published.